PDZ Domain Containing 9 (PDZD9) (Middle Region) Peptid
PDZD9
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle PDZD9 Produkte
- PDZD9 (PDZ Domain Containing 9 (PDZD9))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-C16orf65 antibody (Catalog #: ARP55697_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PDZD9 (PDZ Domain Containing 9 (PDZD9))
- Synonyme
- C16orf65 Peptide, C25H16orf65 Peptide, 4930408O21Rik Peptide, LRRGT00105 Peptide, PDZ domain containing 9 Peptide, PDZD9 Peptide, Pdzd9 Peptide
- Hintergrund
-
The specific function of the protein remains unknown.
Alias Symbols: MGC50721, C16orf65
Protein Size: 202 - Molekulargewicht
- 23 kDa
- Gen-ID
- 255762
- NCBI Accession
- NM_173806, NP_776167
- UniProt
- Q8IXQ8
-
Sie sind hier:
